The difference between the two groups was significant at week 4 (endpoint) (P=0.03). Four adverse events were observed over the study. The difference between the SX and placebo was not significant in the frequency of adverse events.Unfortunately, the funding of the study suggests that there may have been a certain bias towards "proving" the advertisement-claims of the producers and financial supporter of the study, Nature Gift.
|Figure 1: Comparison of baseline and endpoint of the two groups (week 4) based|
on erection domain of IIEF Sscore.NS: non significant and *=P<0.05.